| Date | Title | Description | |
|---|---|---|---|
| 23 Feb 2022 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2021 annual report regarding remuneration of the members of the Board of Directors | Download |
| 23 Feb 2022 | Annual Corporate Governance Report | ROVI releases the 2021 Annual Corporate Governance Report | Download |
| 21 Feb 2022 | Share buy-back , stabilisation and treasury stock programme | Share Buyback Program: transactions conducted between 14 February 2022 and 21 February 2022 | Download |
| 15 Feb 2022 | On business and financial situation | ROVI has announced that the European Commission has authorised the marketing of Okedi® for the treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone. | Download |
| 14 Feb 2022 | Share buy-back , stabilisation and treasury stock programme | Share Buyback Program: transactions conducted between 7 February 2022 and 11 February 2022 | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 24 Feb 2016 | Informe anual de remuneraciones de los consejeros 2015 | ROVI releases the 2015 annual report regarding remuneration of the members of the Board of Directors | Download |
| 23 Dec 2015 | Otros sobre operaciones corporativas | Download | |
| 21 Dec 2015 | Otros sobre operaciones corporativas | Download | |
| 01 Dec 2015 | Otros sobre gobierno corporativo | Download | |
| 01 Dec 2015 | Otros sobre Gobierno Corporativo (2) | Download |